Incline raises $43 million series A to get Ionsys to market
This article was originally published in Scrip
Executive Summary
Incline Therapeutics has raised $43 million in a series A financing round to back the development of Ionsys (fentanyl iontophoretic transdermal system), an analgesic delivery patch that it has licensed from Alza.